- Home
- KRNY vs LAB Comparison
KRNY vs LAB Comparison
Compare KRNY & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KRNY | LAB |
|---|---|---|
| Founded | 1884 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 494.5M | 488.4M |
| IPO Year | 2014 | 2008 |
Fundamental Metrics
Financial Performance| Metric | KRNY | LAB |
|---|---|---|
| Price | $7.60 | $1.03 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $8.00 | $1.35 |
| AVG Volume (30 Days) | 286.8K | ★ 2.0M |
| Earning Date | 04-22-2026 | 05-18-2026 |
| Dividend Yield | ★ 5.63% | N/A |
| EPS Growth | ★ 130.22 | 44.68 |
| EPS | ★ 0.30 | N/A |
| Revenue | $2,580,000.00 | ★ $101,937,000.00 |
| Revenue This Year | $3.89 | N/A |
| Revenue Next Year | $17.52 | $2.63 |
| P/E Ratio | $26.10 | ★ N/A |
| Revenue Growth | ★ 36.00 | N/A |
| 52 Week Low | $5.45 | $0.92 |
| 52 Week High | $8.50 | $1.72 |
Technical Indicators
Market Signals| Indicator | KRNY | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 40.85 | 29.43 |
| Support Level | $6.30 | $0.97 |
| Resistance Level | $7.95 | $1.41 |
| Average True Range (ATR) | 0.26 | 0.07 |
| MACD | -0.06 | -0.00 |
| Stochastic Oscillator | 13.53 | 10.00 |
Price Performance
Historical ComparisonAbout KRNY Kearny Financial Corp
Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. The bank's primary source of income is net interest income.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.